Yuhan Toekomstige groei
Future criteriumcontroles 2/6
Yuhan zal naar verwachting groeien in winst en omzet met respectievelijk 21.7% en 9.7% per jaar. De winst per aandeel zal naar verwachting groeien met 20.8% per jaar. Het rendement op het eigen vermogen zal over 3 jaar naar verwachting 9.3% zijn.
Belangrijke informatie
21.7%
Groei van de winst
20.8%
Groei van de winst per aandeel
Pharmaceuticals winstgroei | 38.3% |
Inkomstengroei | 9.7% |
Toekomstig rendement op eigen vermogen | 9.3% |
Dekking van analisten | Good |
Laatst bijgewerkt | 29 Oct 2024 |
Recente toekomstige groei-updates
Recent updates
Is Yuhan (KRX:000100) Using Too Much Debt?
Oct 08Estimating The Intrinsic Value Of Yuhan Corporation (KRX:000100)
Sep 16Subdued Growth No Barrier To Yuhan Corporation (KRX:000100) With Shares Advancing 41%
Aug 28Yuhan Corporation's (KRX:000100) Price In Tune With Earnings
Jul 01Yuhan Corporation (KRX:000100) Shares Could Be 37% Below Their Intrinsic Value Estimate
Jun 13Yuhan's (KRX:000100) Earnings Are Weaker Than They Seem
May 26Here's Why Yuhan (KRX:000100) Can Manage Its Debt Responsibly
May 13Yuhan Corporation's (KRX:000100) P/E Is Still On The Mark Following 26% Share Price Bounce
Mar 11Yuhan (KRX:000100) Has A Pretty Healthy Balance Sheet
May 01Are Investors Undervaluing Yuhan Corporation (KRX:000100) By 32%?
Apr 16Should You Or Shouldn't You: A Dividend Analysis on Yuhan Corporation (KRX:000100)
Mar 15Are Yuhan Corporation's (KRX:000100) Fundamentals Good Enough to Warrant Buying Given The Stock's Recent Weakness?
Feb 25Is There More To The Story Than Yuhan's (KRX:000100) Earnings Growth?
Feb 10Does Yuhan (KRX:000100) Have A Healthy Balance Sheet?
Jan 28The Yuhan (KRX:000100) Share Price Has Gained 92% And Shareholders Are Hoping For More
Jan 13Is Yuhan Corporation (KRX:000100) Popular Amongst Institutions?
Dec 31Estimating The Fair Value Of Yuhan Corporation (KRX:000100)
Dec 18Is Yuhan Corporation's (KRX:000100) 0.6% Dividend Worth Your Time?
Dec 05Has Yuhan Corporation's (KRX:000100) Impressive Stock Performance Got Anything to Do With Its Fundamentals?
Nov 20Winst- en omzetgroeiprognoses
Datum | Inkomsten | Inkomsten | Vrije kasstroom | Geldmiddelen uit operationele activiteiten | Gem. Aantal analisten |
---|---|---|---|---|---|
12/31/2026 | 2,464,107 | 237,297 | 253,780 | 276,773 | 14 |
12/31/2025 | 2,310,424 | 199,410 | 217,405 | 237,355 | 14 |
12/31/2024 | 2,150,292 | 142,630 | 91,122 | 164,891 | 11 |
6/30/2024 | 1,893,119 | 147,849 | -75,289 | 100,417 | N/A |
3/31/2024 | 1,860,529 | 124,466 | -80,670 | 110,014 | N/A |
12/31/2023 | 1,858,984 | 133,993 | -59,775 | 144,128 | N/A |
9/30/2023 | 1,872,336 | 88,109 | -59,302 | 113,301 | N/A |
6/30/2023 | 1,820,811 | 76,045 | -94,824 | 48,972 | N/A |
3/31/2023 | 1,808,041 | 101,446 | -18,662 | 106,905 | N/A |
12/31/2022 | 1,775,847 | 95,144 | -2,356 | 99,529 | N/A |
9/30/2022 | 1,749,315 | 74,669 | 21,500 | 112,004 | N/A |
6/30/2022 | 1,769,245 | 97,836 | 64,662 | 146,027 | N/A |
3/31/2022 | 1,719,630 | 97,911 | -77,146 | 1,983 | N/A |
12/31/2021 | 1,687,810 | 102,583 | 17,726 | 99,000 | N/A |
9/30/2021 | 1,725,261 | 98,128 | -40,214 | 63,556 | N/A |
6/30/2021 | 1,703,475 | 97,833 | -90,028 | 16,218 | N/A |
3/31/2021 | 1,685,623 | 97,578 | 33,086 | 125,628 | N/A |
12/31/2020 | 1,619,865 | 192,761 | -55,854 | 28,830 | N/A |
9/30/2020 | 1,552,188 | 184,730 | -12,076 | 40,572 | N/A |
6/30/2020 | 1,504,765 | 168,667 | 95,017 | 136,587 | N/A |
3/31/2020 | 1,448,677 | 140,227 | -32,349 | 12,995 | N/A |
12/31/2019 | 1,480,354 | 40,006 | 19,251 | 65,985 | N/A |
9/30/2019 | 1,500,782 | 44,230 | 22,262 | 71,414 | N/A |
6/30/2019 | 1,497,130 | 41,438 | -43,955 | 1,332 | N/A |
3/31/2019 | 1,523,954 | 52,333 | 109,427 | 156,727 | N/A |
12/31/2018 | 1,518,823 | 57,481 | 45,602 | 93,452 | N/A |
9/30/2018 | 1,481,906 | 70,146 | 54,109 | 108,573 | N/A |
6/30/2018 | 1,482,034 | 84,572 | 48,987 | 107,587 | N/A |
3/31/2018 | 1,450,870 | 100,288 | N/A | 112,160 | N/A |
12/31/2017 | 1,462,248 | 109,034 | N/A | 126,125 | N/A |
9/30/2017 | 1,434,749 | 139,325 | N/A | 116,234 | N/A |
6/30/2017 | 1,417,835 | 137,434 | N/A | 135,085 | N/A |
3/31/2017 | 1,395,518 | 139,440 | N/A | 142,224 | N/A |
12/31/2016 | 1,320,797 | 161,249 | N/A | 74,144 | N/A |
9/30/2016 | 1,274,011 | 134,997 | N/A | 98,827 | N/A |
6/30/2016 | 1,223,925 | 155,819 | N/A | 97,292 | N/A |
3/31/2016 | 1,163,130 | 152,682 | N/A | 88,684 | N/A |
12/31/2015 | 1,128,731 | 126,047 | N/A | 126,235 | N/A |
9/30/2015 | 1,097,229 | 118,104 | N/A | 120,389 | N/A |
6/30/2015 | 1,046,716 | 98,362 | N/A | 140,058 | N/A |
3/31/2015 | 1,031,875 | 94,628 | N/A | 71,402 | N/A |
12/31/2014 | 1,017,492 | 90,948 | N/A | 94,386 | N/A |
9/30/2014 | 1,007,109 | 95,434 | N/A | 78,642 | N/A |
6/30/2014 | 970,253 | 87,696 | N/A | 44,515 | N/A |
3/31/2014 | 953,191 | 83,863 | N/A | 56,486 | N/A |
12/31/2013 | 943,609 | 86,461 | N/A | 79,778 | N/A |
Toekomstige groeivoorspellingen analisten
Verdiensten versus spaarpercentage: De verwachte winstgroei A000100 ( 21.7% per jaar) ligt boven de spaarquote ( 2.6% ).
Winst versus markt: De winst van A000100 ( 21.7% per jaar) zal naar verwachting langzamer groeien dan de markt KR ( 30.3% per jaar).
Hoge groeiwinsten: De winst van A000100 zal naar verwachting de komende 3 jaar aanzienlijk groeien.
Omzet versus markt: De omzet van A000100 ( 9.7% per jaar) zal naar verwachting langzamer groeien dan de markt KR ( 10.2% per jaar).
Hoge groei-inkomsten: De omzet van A000100 ( 9.7% per jaar) zal naar verwachting langzamer groeien dan 20% per jaar.
Groeiprognoses winst per aandeel
Toekomstig rendement op eigen vermogen
Toekomstige ROE: Het rendement op eigen vermogen A000100 zal naar verwachting over 3 jaar laag zijn ( 9.3 %).